ERBB2 and breast cancer: A decreasing endogenous MDM2 level (using specific siRNA) in different breast cancer cell lines led to the same conclusions: only in the case of SKBR3 cells (which represent the HER2 subtype of breast cancer) did downregulation of MDM2 gene result in the decrease in cell survival.